Articles by Andrew Sinclair - BioPharm International

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search

ADVERTISEMENT

Articles by Andrew Sinclair

Andrew Sinclair

Managing Director of Biopharm Services

Articles
The Role of Disposables in Rapid Response Manufacturing
August 1, 2009

Single-use technologies can be configured and installed fairly quickly, but are they ready to handle the urgency and scale of a pandemic?

User Viewpoints on Disposables Implementation
June 1, 2009

What end users think about single-use systems.

Disposables Cost Contributions: A Sensitivity Analysis
April 1, 2009

Cost modeling provides valuable insights to support strategic decision-making when implementing disposable technologies.

Evaluating Disposable Mixing Systems
February 1, 2009

How to choose a disposable mixing system that fits your particular needs.

Disposable Technologies Implementation: Understanding and Managing Risks
December 1, 2008

In new disposables projects, it is critical that engineering, procurement, and operations groups work together early on to manage supply chain risk.

The Environmental Impact of Disposable Technologies
November 2, 2008

Can disposables reduce your facility's environmental footprint? We have compared the environmental footprint of a traditional biopharmaceutical manufacturing facility using fixed-in-place stainless steel equipment, and a facility implementing disposable technologies for cell culture, solution mixing and hold, product hold, and liquid transfer.

Disposables Open Up Possibilities in Facility Design
August 1, 2008

In addition to making technical developments, vendors are also looking at ways to improve supply-chain security. By offering standard, off-the-shelf products, vendors are able to shorten lead times and improve the security of supply.

How to Evaluate the Cost Impact of Using Disposables in Biomanufacturing
June 1, 2008

The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.

Disposable Bioreactors: The Next Generation
April 1, 2008

Disposable technologies that mimic the conventional stainless-steel bioreactor will be most readily adopted

ADVERTISEMENT

ADVERTISEMENT

Advertiser Gallery
Click here